Nederlands
Bahasa Indo
Eli Lilly Stock Just Got Even Sweeter. Here's Why It's Worth Buying Now
According to a sneak peek of the data from one of Eli Lilly 's (NYSE: LLY) late-stage clinical trials, the cardiometabolic medicine juggernaut now looks even ... Read more
Bron: 
Fool.com: The Motley Fool
Fool.com: The Motley Fool
Tags: Eli Lilly, Novo Nordisk
Geplaatst: 09 Dec 2024 - 10:59
